{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:19:56Z","timestamp":1781212796359,"version":"3.54.1"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"French \u201cProgramme Hospitalier de Recherche Clinique\u201d"},{"name":"ANR","award":["RHU FIGHT-HF (ANR-15-RHU-0004)"],"award-info":[{"award-number":["RHU FIGHT-HF (ANR-15-RHU-0004)"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0232572","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:55:12Z","timestamp":1589219712000},"page":"e0232572","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Plasma Galectin-3 predicts deleterious vascular dysfunction affecting post-myocardial infarction patients: An explanatory study"],"prefix":"10.1371","volume":"15","author":[{"given":"Olivier","family":"Huttin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Mandry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batric","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Odille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilien","family":"Micard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohra","family":"Lamiral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa\u00efez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7319-3737","authenticated-orcid":true,"given":"Pierre-Yves","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"issue":"1","key":"pone.0232572.ref001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12968-016-0314-6","article-title":"Cardiac remodeling following reperfused acute myocardial infarction is linked to the concomitant evolution of vascular function as assessed by cardiovascular magnetic resonance","volume":"19","author":"O Huttin","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"pone.0232572.ref002","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1016\/j.amjhyper.2004.11.024","article-title":"Systolic blood pressure does not reliably identify vasoactive status in chronic heart failure","volume":"18","author":"CW1 Parrott","year":"2005","journal-title":"Am J Hypertens"},{"issue":"5","key":"pone.0232572.ref003","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/HJH.0000000000000889","article-title":"Comprehensive monitoring of cardiac remodeling with aortic stroke volume values provided by a phase-contrast MRI sequence","volume":"34","author":"PY Marie","year":"2016","journal-title":"J Hypertens"},{"key":"pone.0232572.ref004","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/HJH.0b013e32834f6f3f","article-title":"Comprehensive MRI analysis of early cardiac and vascular remodeling in middle-aged patients with abdominal obesity","volume":"30","author":"D Mandry","year":"2012","journal-title":"J Hypertens"},{"issue":"9","key":"pone.0232572.ref005","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1586\/erc.12.108","article-title":"Reassessing the use of vasodilators in heart failure","volume":"10","author":"RT Cole","year":"2012","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"6","key":"pone.0232572.ref006","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"L Te Riet","year":"2015","journal-title":"Circ Res"},{"issue":"1","key":"pone.0232572.ref007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/hr.2009.184","article-title":"Reinventing the ACE inhibitors: some old and new implications of ACE inhibition","volume":"33","author":"K Hanif","year":"2010","journal-title":"Hypertens Res"},{"issue":"4","key":"pone.0232572.ref008","doi-asserted-by":"crossref","first-page":"897","DOI":"10.5114\/aoms.2016.58664","article-title":"Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and Galectin-3","volume":"13","author":"S Hogas","year":"2017","journal-title":"Arch Med Sci"},{"issue":"1","key":"pone.0232572.ref009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/clc.23105","article-title":"Association of Galectin-3 with markers of myocardial function, atherosclerosis, and vascular fibrosis in patients with rheumatoid arthritis","volume":"42","author":"P Anyfanti","year":"2019","journal-title":"Clin Cardiol"},{"issue":"11","key":"pone.0232572.ref010","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2010.04.040","article-title":"Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction","volume":"56","author":"MT Maeder","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"pone.0232572.ref011","doi-asserted-by":"crossref","first-page":"e0119432","DOI":"10.1371\/journal.pone.0119432","article-title":"Relationship of exercise capacity and left ventricular dimensions in patients with a normal ejection fraction. An exploratory study","volume":"10","author":"M Meyer","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pone.0232572.ref012","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/HYPERTENSIONAHA.115.05431","article-title":"Neutrophil Gelatinase-Associated Lipocalin, a Novel Mineralocorticoid Biotarget, Mediates Vascular Profibrotic Effects of Mineralocorticoids","volume":"66","author":"A Tarjus","year":"2015","journal-title":"Hypertension"},{"issue":"1","key":"pone.0232572.ref013","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","article-title":"Galectin-3 mediates aldosterone-induced vascular fibrosis","volume":"33","author":"L Calvier","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"pone.0232572.ref014","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"AS Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0232572.ref015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40292-019-00320-w","article-title":"Vascular Aging and Disease of the Small Vessels","volume":"26","author":"D Rizzoni","year":"2019","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"12","key":"pone.0232572.ref016","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jcmg.2015.10.005","article-title":"Association between myocardial mechanics and ischemic LV remodeling","volume":"8","author":"N D'Elia","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"pone.0232572.ref017","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1161\/HYPERTENSIONAHA.115.05159","article-title":"Independent associations of circulating galectin-3 concentrations with aortic pulse wave velocity and wave reflection in a community sample","volume":"65","author":"E Libhaber","year":"2015","journal-title":"Hypertension"},{"key":"pone.0232572.ref018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.114.000785","article-title":"Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis","volume":"3","author":"J Madrigal-Matute","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"pone.0232572.ref019","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cvr\/cvt206","article-title":"The galectin-3\/RAGE dyad modulates vascular osteogenesis in atherosclerosis","volume":"100","author":"S Menini","year":"2013","journal-title":"Cardiovasc Res"},{"key":"pone.0232572.ref020","article-title":"Value of Galectin-3 in Acute Myocardial Infarction","author":"M Li","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"key":"pone.0232572.ref021","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"62","author":"CW Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"pone.0232572.ref022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2015.05.040","article-title":"Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort","volume":"192","author":"A Jagodzinski","year":"2015","journal-title":"Int J Cardiol"},{"key":"pone.0232572.ref023","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijcard.2007.01.089","article-title":"Patterns of left ventricular hypertrophy in essential hypertension: should echocardiography guide the pharmacological treatment?","volume":"124","author":"DF D\u00e1vila","year":"2008","journal-title":"Int J Cardiol"},{"key":"pone.0232572.ref024","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/eurheartj\/ehi705","article-title":"Long term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction","volume":"27","author":"GH Gislason","year":"2006","journal-title":"European Heart Journal"},{"issue":"4","key":"pone.0232572.ref025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00228-013-1614-5","article-title":"Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France","volume":"70","author":"J Bezin","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"pone.0232572.ref026","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCOUTCOMES.109.919415","article-title":"Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge","volume":"3","author":"AJ Bagnall","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"pone.0232572.ref027","doi-asserted-by":"crossref","first-page":"593","DOI":"10.7150\/thno.22196","article-title":"Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update","volume":"8","author":"N Suthahar","year":"2018","journal-title":"Theranostics"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232572","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:55:38Z","timestamp":1589219738000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0232572"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"And\u00f2","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0232572","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]}}}